Massachusetts news topic
Treatment updates
Every Massachusetts update we have published on treatment updates, newest first. Each report names the primary source so you can check it yourself.
September 25, 2026
BrainsWay says FDA cleared accelerated Deep TMS protocol
BrainsWay said the FDA cleared an accelerated Deep TMS protocol for major depressive disorder, with an acute phase of six treatment days rather than four weeks in the previous schedule.
Primary source: BrainsWay via GlobeNewswire (Burlington, Mass.)
September 25, 2026
TMS described as option for treatment-resistant depression
Boston Medical Center HealthCity says TMS is an FDA-approved, non-invasive, evidence-based option for depression when other treatments have failed, according to its report.
Primary source: Boston Medical Center HealthCity
September 25, 2026
fMRI-Guided Accelerated TMS Outperformed Conventional Targeting
Brain & Behavior Research Foundation reports a head-to-head trial in which individualized fMRI-guided accelerated TMS outperformed conventional scalp-measurement targeting.
Primary source: Brain & Behavior Research Foundation
September 25, 2026
TMS Therapy Offering Reported in Lawrence
Mental Health Network reports that TMS is now offered in Lawrence for certain people with depression or OCD who have not responded adequately to prior care.
Primary source: Mental Health Network
September 25, 2026
Personalized Imaging May Improve TMS Targeting for Depression
Mass General Brigham reports that a randomized trial found personalized functional MRI-guided TMS targeting may improve outcomes for treatment-resistant depression.
Primary source: Mass General Brigham
September 25, 2026
NBC Boston reports five-day accelerated TMS in Belmont
NBC Boston reports that a Belmont hospital is using a five-day accelerated TMS schedule for treatment-resistant depression, anxiety and OCD.
Primary source: NBC Boston